Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Schizophrenia”

176 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 176 results

Testing effectiveness (Phase 2)Study completedNCT03751280
What this trial is testing

Study of Efficacy of PEAR-004 in Schizophrenia

Who this might be right for
Schizophrenia
Novartis Pharmaceuticals 112
Large-scale testing (Phase 3)Study completedNCT03870880
What this trial is testing

Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension

Who this might be right for
Schizophrenia
Rovi Pharmaceuticals Laboratories 215
Large-scale testing (Phase 3)Study completedNCT00790192
What this trial is testing

Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.

Who this might be right for
Schizophrenia
Sumitomo Pharma America, Inc. 488
Testing effectiveness (Phase 2)Study completedNCT00628290
What this trial is testing

Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis

Who this might be right for
Schizophrenia
University of Cologne 42
Not applicableStudy completedNCT07364825
What this trial is testing

Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care

Who this might be right for
PsychosisAnxietyDepression+1 more
Brigham and Women's Hospital 41
Testing effectiveness (Phase 2)Study completedNCT04624243
What this trial is testing

Efficacy and Safety of Elpipodect (MK-8189) in Participants With an Acute Episode of Schizophrenia (MK-8189-008)

Who this might be right for
Schizophrenia
Merck Sharp & Dohme LLC 499
Large-scale testing (Phase 3)Study completedNCT01810380
What this trial is testing

Brexpiprazole in Patients With Acute Schizophrenia

Who this might be right for
Schizophrenia
H. Lundbeck A/S 468
Large-scale testing (Phase 3)Study completedNCT01668797
What this trial is testing

Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia

Who this might be right for
Acute Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 524
Large-scale testing (Phase 3)Study completedNCT01098110
What this trial is testing

6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124)

Who this might be right for
Schizophrenia
Organon and Co 532
Not applicableStudy completedNCT04874974
What this trial is testing

Feasibility of a Novel Process-based Treatment for Patients With Psychosis

Who this might be right for
SchizophreniaSchizotypal DisorderDelusional Disorder+10 more
Max-Planck-Institute of Psychiatry 37
Testing effectiveness (Phase 2)Study completedNCT05278156
What this trial is testing

Efficacy, Safety and Pharmacokinetics Study of CPL500036 (PDE10A Inhibitor) in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Celon Pharma SA 189
Large-scale testing (Phase 3)Study completedNCT00254202
What this trial is testing

Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia

Who this might be right for
Schizophrenia
Vanda Pharmaceuticals 593
Testing effectiveness (Phase 2)Study completedNCT05227703
What this trial is testing

A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia

Who this might be right for
Schizophrenia
AbbVie 391
Not applicableStudy completedNCT05633108
What this trial is testing

A Study Based on the French National Health Insurance Database in Participants With Psychotic Disorders

Who this might be right for
Psychotic Disorders
Eisai Co., Ltd. 579,728
Not applicableStudy completedNCT01610011
What this trial is testing

Acute Glycine Pharmacodynamic Study

Who this might be right for
SchizophreniaPsychotic Disorders
Mclean Hospital 21
Very early researchEnded earlyNCT02335060
What this trial is testing

N-acetylcysteine Effects on Tetrahydrocannabinol

Who this might be right for
Healthy
Yale University 5
Testing effectiveness (Phase 2)Study completedNCT02151656
What this trial is testing

F17464 in Acute Schizophrenia Trial

Who this might be right for
Schizophrenia
Pierre Fabre Medicament 158
Large-scale testing (Phase 3)Study completedNCT01104766
What this trial is testing

Safety and Efficacy of Cariprazine in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Forest Laboratories 617
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07521683
What this trial is testing

A Phase II Clinical Study to Evaluate the Efficacy and Safety of NS-136 in the Treatment of Schizophrenia

Who this might be right for
Schizophrenia(Acute)
NeuShen Therapeutics 150
Testing effectiveness (Phase 2)Study completedNCT04512066
What this trial is testing

A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

Who this might be right for
Schizophrenia, Schizoaffective Disorder
Hoffmann-La Roche 287
Next Page